Report
Pharmacy in Focus: Unlocking the promise of biosimilars
In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
Read More
Article
Study finds GLP-1s show potential for managing comorbid depression and anxiety
GLP-1s may offer benefits beyond managing blood sugar.
Read More
Article
Independent analysis demonstrates value of pharmacy benefit managers in the U.S.
Read the findings from Avalere Health's latest paper, “The Role of PBMs in the U.S. Healthcare System,” to learn how pharmacy benefit managers drive savings and unlock better health outcomes.
Read MoreReport
Study: Social determinants of health influence breast cancer outcomes
April 16, 2025
To better understand how socioeconomic disparities impact breast cancer screening and care, the Evernorth Research Institute analyzed claims data of more than 168,000 women covered by commercial healt...
Report
Pharmacy in Focus: Navigating GLP-1 cost, demand and sustainability
March 25, 2025
With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.
Report
Respiratory illnesses are on the rise this season across the U.S.
Evernorth data shows fewer prescriptions have been filled for certain anti-viral medications than in previous years, but an uptick in January shows that respiratory illnesses are circulating in the U....
Read More